In particular, SHIP1-selective chemical inhibitor 3AC (3α-aminocholestane) is able to block multiple myeloma (MM) cell lines, inducing apoptosis, and cell cycle arrest. The gene discussed is INPP5D; the disease is Miyoshi myopathy.